Announcements Trials
Browse Landscape

Phase

Phase NA 19Phase 2 12Phase 1 5Phase 3 4Phase 4 3Phase EARLY_PHASE1 2Phase 2/3 1Phase 1/2 1

Status

Completed 28Recruiting 10Unknown 8Not yet recruiting 3Terminated 2Withdrawn 1Enrolling by invitation 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Gastrointestinal 31Breast 23Gynecologic 11Lymphoid 10Thoracic 9Plasma cell 7Other hematologic neoplasm 7Genitourinary 7Classical hematology 7Dermatologic 5Other 4Head & Neck 4Endocrine 3Myeloid 2CNS 2Sarcoma 1Other solid neoplasm 1NET 1

Conditions

Thyroid Cancer, Papillary 1Neuroendocrine Tumors 1Carcinoma, Neuroendocrine 1

Interventions

Mitoxantrone 1Fluorouracil 1Cisplatin 1Carboplatin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 4 × Not yet recruiting × Endocrine × Clear all
NCT07354698 2026-01-21

MHI

Daping Hospital and the Research Institute of Surgery of the Third Military Medical University

Phase 4 Not yet recruiting
114 enrolled
EndocrineHead & Neck

Thyroid Cancer, Papillary

NCT07014540 2025-06-11

A Irinotecan Liposome Trial of in Advanced Neuroendocrine Carcinoma

Beijing GoBroad Hospital

Phase 4 Not yet recruiting
45 enrolled
Endocrine

Carcinoma, Neuroendocrine

NCT06485739 2024-07-03

Irinotecan Liposomes for the Treatment of Neuroendocrine Carcinoma

First Affiliated Hospital Xi'an Jiaotong University

Phase 4 Not yet recruiting
20 enrolled
EndocrineNET

Neuroendocrine Tumors

Data powered by HemOnc (CC BY 4.0) Colophon âš¡